Professor Alan Jardine

  • Professor (Institute of Cardiovascular and Medical Sciences)
  • Associate Academic (Institute of Infection Immunity and Inflammation)

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Detection of uraemic myocardial fibrosis with non-contrast cardiac magnetic resonance imaging
    Kidney Research UK
    2014 - 2016
     
  • WIG Heart Failure
    NHS Greater Glasgow & Clyde, Endowment Funds Office
    2014 - 2014
     
  • MINeralocorticoid Dysregulation in Chronic Kidney Disease (MIND-CKD)
    Kidney Research UK
    2013 - 2015
     
  • MRI Fellow
    NHS Greater Glasgow & Clyde
    2012 - 2013
     
  • Serum phosphate as a cardiovascular risk factor: effects on vascular and endothelial function
    British Heart Foundation
    2012 - 2013
     
  • sysKID
    European Commission
    2010 - 2014
     
  • Microvolt T wave alternans, uraemic cardiomyopathy and QT dispersion in end stage renal failure patients: prognostic value for cardiac arrhythmia, sudden cardiac death, and all cause mortality
    British Heart Foundation
    2008 - 2010
     
  • A novel gene therapy approach to treatment of renal disease
    Kidney Research UK
    2006 - 2008
     
  • A National DNA Bank for Glomerulonephritis
    North Glasgow University Hospitals NHS Trust
    2005 - 2005
     
  • Investigating the frequency and causes of anaemia in patients with chronic heart failure
    Scottish Executive Health Department
    2005 - 2009
     
  • Redefinition of uraemic cardiomyopathy and vascular disease using carotoid and cardiac MRI
    British Heart Foundation
    2003 - 2006
     
  • A National DNA Bank for Glomerulonephritis
    MRC
    2001 - 2005
     

Additional information

Editorial Board

  • 2011 - 2016: BMC Transplantation Research - Editor in Chief
  • 2007 - 2012: Transplantation - Member
  • 2005 - ongoing: British Journal of Transplantation - Member
  • 2002 - ongoing: Nephron - Associate Editor
  • 2000 - 2005: Transplant Topics - Member
  • 2000 - 2005: Journal of Nephrology - Member

Grant Advisory Board

  • 2007 - 2010: British Medical Association (BMA) - Member of the Scottish Medical Academic Staff Committee
  • 2007 - ongoing: British Medical Association (BMA) - Member of the Scottish Consultants Committee
  • 2006 - 2009: Association of Physicians of the UK & Ireland - Local Secretary and Executive Member for West of Scotland
  • 2006 - 2009: National Kidney Research Fund (KRUK) - Member of Fellowship Committee
  • 2006 - 2009: National Kidney Research Fund (KRUK) - Member of the Fellowship Committee
  • 2005 - 2012: National Kidney Research Fund (KRUK) - Member of Grants Committee
  • 2005 - 2012: National Kidney Research Fund (KRUK) - Member of KRUK Grants Committee
  • 2004 - 2009: Joint Committee on Higher Medical Training - Member of the Academic and Research Sub-Committee
  • 2003 - 2003: International Diabetes Foundation - Member of Working Group on Post-Transplant Diabetes
  • 2002 - ongoing: Chief Scientist Office (CSO) - Member of CSO Diabetes Research Group

Professional Learned Society

  • 2013 - ongoing: American Society of Nephrology - Fellow (F.A.S.N.)
  • 2011 - ongoing: European Board of Surgery (Transplant Medicine) - Fellow (F.E.B.S.)
  • 2009 - ongoing: European Society of Cardiology - Fellow (F.E.S.C.)

Publications

List by: Type | Date

Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1992
Number of items: 168.

2017

Rutherford, E., Stewart, G., Houston, J. G., Jardine, A. G. , Mark, P. B. and Struthers, A. D. (2017) An open-label dose-finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients. Journal of Clinical Pharmacology, (doi:10.1002/jcph.939) (PMID:28597919) (Early Online Publication)

Holdaas, H., Mjøen, G. and Jardine, A. G. (2017) Belatacept: where the BENEFITS outweigh the risk. American Journal of Kidney Diseases, 69(5), pp. 561-563. (doi:10.1053/j.ajkd.2017.02.007) (PMID:28434523)

Rose, J., Emery, V. C., Kumar, D., Asberg, A., Hartmann, A., Jardine, A. G. , Bignamini, A. A., Humar, A. and Neumann, A. U. (2017) Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection. PLoS Pathogens, 13(4), e1006299. (doi:10.1371/journal.ppat.1006299) (PMID:28406982) (PMCID:PMC5391089)

Neuberger, J. M. et al. (2017) Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) group. Transplantation, 101(4 S2), S1-S56. (doi:10.1097/TP.0000000000001651) (PMID:28328734)

Fellström, B. C. et al. (2017) Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet, (doi:10.1016/S0140-6736(17)30550-0) (In Press)

Rutherford, E., Weir-McCall, J. R., Patel, R. K., Houston, J. G., Roditi, G., Struthers, A. D., Jardine, A. G. and Mark, P. B. (2017) Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings. European Radiology, 27(1), pp. 315-324. (doi:10.1007/s00330-016-4288-4) (PMID:27053260)

2016

Solbu, M. D., Mjøen, G., Mark, P. B. , Holdaas, H., Fellström, B., Schmieder, R. E., Zannad, F., Herrington, W. G. and Jardine, A. (2016) Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA Study. Nephrology Dialysis Transplantation, (doi:10.1093/ndt/gfw360) (PMID:27798199) (Early Online Publication)

Rutherford, E. et al. (2016) Definition of myocardial tissue abnormalities in end stage renal failure with cardiac magnetic resonance imaging using T1 mapping. Kidney International, 90(4), pp. 845-852. (doi:10.1016/j.kint.2016.06.014)

Currie, G. et al. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, 127. (doi:10.1186/s12882-016-0337-0) (PMID:27609359) (PMCID:PMC5015203)

Findlay, M. D. et al. (2016) Risk factors and outcome of stroke in renal transplant recipients. Clinical Transplantation, 30(8), pp. 918-924. (doi:10.1111/ctr.12765) (PMID:27218240)

Herrington, W. G. et al. (2016) Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes and Endocrinology, 4(10), pp. 829-839. (doi:10.1016/S2213-8587(16)30156-5) (PMID:27477773)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B. , Kettlewell, S., Smith, G. L. , Clancy, M. J., Delles, C. and Jardine, A. G. (2016) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, (doi:10.1093/ndt/gfw252) (PMID:27448672) (Early Online Publication)

Solbu, M. D. and Jardine, A. G. (2016) ‘To block or not to block’; whether to continue renin–angiotensin–aldosterone system blockade in advanced chronic kidney disease. Nephrology Dialysis Transplantation, 31(2), pp. 171-173. (doi:10.1093/ndt/gfv351) (PMID:26445812)

2015

Solbu, M. D., Thomson, P. C., Macpherson, S., Findlay, M. D., Stevens, K. K., Patel, R. K., Padmanabhan, S. , Jardine, A. G. and Mark, P. B. (2015) Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease. BMC nephrology, 16(1), 194. (doi:10.1186/s12882-015-0187-1) (PMID:26627078) (PMCID:PMC4666082)

Patel, R., Jeemon, P., Stevens, K., Mccallum, L., Hastie, C., Schneider, A., Jardine, A. , Mark, P. and Padmanabhan, S. (2015) Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults. Journal of Hypertension, 33(10), pp. 2046-2053. (doi:10.1097/hjh.0000000000000659) (PMID:26431193)

Findlay, M. D., Thomson, P. C., Fulton, R. L., Solbu, M. D., Jardine, A. G. , Patel, R. K., Stevens, K. K., Geddes, C. C., Dawson, J. and Mark, P. B. (2015) Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients. Stroke, 46(9), pp. 2477-2481. (doi:10.1161/STROKEAHA.115.009095) (PMID:26230856)

Lees, J. S., Mark, P. B. and Jardine, A. G. (2015) Cardiovascular complications of chronic kidney disease. Medicine, 43(8), pp. 469-473. (doi:10.1016/j.mpmed.2015.05.009)

Drechsler, C. et al. (2015) Homoarginine and clinical outcomes in renal transplant recipients. Transplantation, 99(7), pp. 1470-1476. (doi:10.1097/tp.0000000000000568) (PMID:25675199)

Oliver, S.W., Thomson, P.C. and Jardine, A.G. (2015) Safe central venous catheter insertion practice must extend beyond simply measuring catheter-associated bloodstream infections. Journal of Hospital Infection, 90(1), p. 81. (doi:10.1016/j.jhin.2014.11.021) (PMID:25617090)

Stoumpos, S., Jardine, A. G. and Mark, P. B. (2015) Cardiovascular morbidity and mortality after kidney transplantation. Transplant International, 28(1), pp. 10-21. (doi:10.1111/tri.12413) (PMID:25081992)

Ueland, T., Rollag, H., Hartmann, A., Jardine, A., Humar, A., Bignamini, A. A., Åsberg, A. and Aukrust, P. (2015) Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients. Transplantation, 99(1), pp. 100-105. (doi:10.1097/TP.0000000000000227)

Jardine, A. G. (2015) Con: Ambulatory blood pressure measurement in patients receiving haemodialysis: a sore arm and a waste of time? Nephrology Dialysis Transplantation, 30(9), pp. 1438-1441. (doi:10.1093/ndt/gfv244) (PMID:26022726) (PMCID:26022726)

Jardine, A. G. (2015) Opponent's comments. Nephrology Dialysis Transplantation, 30(9), pp. 1437-1438. (doi:10.1093/ndt/gfv243a) (PMID:26311657)

So, B. H., Methven, S., Hair, M. D., Jardine, A. G. and MacGregor, M. S. (2015) Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrology Dialysis Transplantation, 30(6), pp. 1010-1017. (doi:10.1093/ndt/gfu408) (PMID:25586406)

2014

Hirsch, H.H. et al. (2014) European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clinical Microbiology and Infection, 20(Sup 7), pp. 74-88. (doi:10.1111/1469-0691.12538)

Sharif, A. et al. (2014) Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. American Journal of Transplantation, 14(9), pp. 1992-2000. (doi:10.1111/ajt.12850)

Holdaas, H. and Jardine, A. G. (2014) BP targets in renal transplant recipients: too high or too low? Journal of the American Society of Nephrology, 25(7), pp. 1371-1373. (doi:10.1681/ASN.2014020177)

Mark, P. B., Taylor, A. H. M., McQuarrie, E. P. and Jardine, A. G. (2014) How is the heart best protected in chronic dialysis patients? Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients. Seminars in Dialysis, 27(4), pp. 328-332. (doi:10.1111/sdi.12178)

McQuarrie, E. P., Traynor, J. P., Taylor, A. H., Freel, E. M., Fox, J. G., Jardine, A. G. and Mark, P. (2014) Association between urinary sodium, creatinine, albumin, and long term survival in chronic kidney disease. Hypertension, 64(1), pp. 111-117. (doi:10.1161/HYPERTENSIONAHA.113.03093)

Gillis, K. A., Patel, R. K. and Jardine, A. G. (2014) Cardiovascular complications after transplantation: treatment options in solid organ recipients. Transplantation Reviews, 28(2), pp. 47-55. (doi:10.1016/j.trre.2013.12.001)

Fellstrom, B., Holdaas, H. and Jardine, A. (2014) Functional cardiopulmonary exercise testing in potential renal transplant recipients. Journal of the American Society of Nephrology, 25(1), pp. 8-9. (doi:10.1681/ASN.2013090996)

Pihlstrøm, H., Mjøen, G., März, W., Olav Dahle, D., Abedini, S., Holme, I., Fellström, B., Jardine, A., Pilz, S. and Holdaas, H. (2014) Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients. Clinical Transplantation, 28(1), pp. 111-119. (doi:10.1111/ctr.12285) (PMID:24372612) (PMCID:PMC4204514)

Ueland, T., Rollag, H., Hartmann, A., Jardine, A.G., Humar, A., Michelsen, A.E., Bignamini, A.A., Åsberg, A. and Aukrust, P. (2014) Secreted wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients. American Journal of Transplantation, 14(1), pp. 210-215. (doi:10.1111/ajt.12506)

Gillis, K.A. et al. (2014) Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla. BMC Nephrology, 15(23), (doi:10.1186/1471-2369-15-23)

2013

Schjelderup, P., Dahle, D.O., Holdaas, H., Mjøen, G., Nordby, G., Abedini, S., Jardine, A., Fellström, B. and Svensson, M. (2013) Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study. Clinical Transplantation, 27(6), E636-E643. (doi:10.1111/ctr.12220)

Patel, R.K., Taylor, A. and Jardine, A.G. (2013) Prophylactic ciprofloxacin for kidney transplant recipients—to add or not to add. Transplantation, 96(4), pp. 370-371. (doi:10.1097/TP.0b013e31829e2723)

Stevens, K.K., Patel, R.K., Methven, S., Clancy, M.J., Fox, J.G., Jardine, A.G. and Geddes, C.C. (2013) Proteinuria and outcome after renal transplantation. Transplantation, 96(1), pp. 65-69. (doi:10.1097/TP.0b013e318295852c)

McQuarrie, E.P., Freel, E.M., Mark, P.B. , Fraser, R., Connell, J.M.C. and Jardine, A.G. (2013) Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 28(6), pp. 1526-1532. (doi:10.1093/ndt/gft007)

Patel, R.K., Stevens, K.K. and Jardine, A.G. (2013) Sleep apnoea and the potential benefits of a good night's sleep in patients receiving maintenance dialysis. Nephrology Dialysis Transplantation, 28(4), pp. 777-778. (doi:10.1093/ndt/gfs532)

Brennan, D.C., Aguado, J.M., Potena, L., Jardine, A.G., Legendre, C., Säemann, M.D., Mueller, N.J., Merville, P., Emery, V. and Nashan, B. (2013) Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Reviews in Medical Virology, 23(2), pp. 97-125. (doi:10.1002/rmv.1733)

Schneider, A., Jardine, A.G., Schneider, M.P., Holdaas, H., Holme, I., Fellstroem, B.C., Zannad, F. and Schmieder, R.E. (2013) Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study. American Journal of Nephrology, 37(2), pp. 144-151. (doi:10.1159/000346710)

Holme, I., Fellstrom, B.C., Jardine, A.G., Hartmann, A. and Holdaas, H. (2013) Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients. Clinical Journal of the American Society of Nephrology, 8(2), pp. 241-247. (doi:10.2215/CJN.03760412)

Soveri, I., Snyder, J., Holdaas, H., Holme, I., Jardine, A.G., L’Italien, G.J. and Fellström, B. (2013) The external validation of the cardiovascular risk equation for renal transplant recipients. Transplantation, 95(1), pp. 142-147. (doi:10.1097/TP.0b013e31827722c9)

Mark, P., Stevens, K. and Jardine, A. (2013) Electrolytes: acid–base balance. In: Caballero, B., Allen, L. and Prentice, A. (eds.) Encyclopedia of Human Nutrition. Academic Press: Waltham, MA, pp. 139-145. ISBN 9780123750839

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1), pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Schneider, A., Schneider, M.P., Scharnagl, H., Jardine, A.G., Wanner, C. and Drechsler, C. (2013) Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes. BMC Nephrology, 14(67), (doi:10.1186/1471-2369-14-67)

Tonelli, M.A. et al. (2013) Introduction: the case for updating and context. Kidney International Supplements, 3(3), pp. 266-267. (doi:10.1038/kisup.2013.32)

2012

Holdaas, H. and Jardine, A. (2012) Chronic kidney disease: do patients with CKD benefit from lipid-lowering therapy? Nature Reviews Nephrology, 8(12), pp. 684-685. (doi:10.1038/nrneph.2012.240)

Freel, E. M., Mark, P. B., Weir, R. A.P., McQuarrie, E. P., Allan, K., Dargie, H. J., McClure, J. D., Jardine, A. G., Davies, E. and Connell, J. M.C. (2012) Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circulation: Cardiovascular Imaging, 5(6), pp. 740-747. (doi:10.1161/CIRCIMAGING.112.974576)

Velasco, N. et al. (2012) Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients. Hemodialysis International, 16(4), pp. 465-472. (doi:10.1111/j.1542-4758.2012.00689.x)

McQuarrie, E. P., Freel, E. M., Mark, P. B., Fraser, R., Patel, R. K., Dargie, H. G., Connell, J. M. C. and Jardine, A. G. (2012) Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease. Clinical Science, 123(5), pp. 285-294. (doi:10.1042/CS20120015)

Soveri, I., Holme, I., Holdaas, H., Budde, K., Jardine, A.G. and Fellström, B. (2012) A cardiovascular risk calculator for renal transplant recipients. Transplantation, 94(1), pp. 57-62. (doi:10.1097/TP.0b013e3182516cdc)

Mark, P. and Jardine, A. (2012) Assessment of the potential renal transplant recipient. In: MacPhee, I. A. M. and Froněck, J. (eds.) Handbook of Renal and Pancreatic Transplantation. Wiley-Blackwell: Oxford, pp. 8-31. ISBN 9780470654910

Svensson, M., Dahle, D.O., Mjoen, G., Weihrauch, G., Marz, W., Jardine, A., Fellstrom, B. and Holdaas, H. (2012) Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. Nephrology Dialysis Transplantation, 27(6), pp. 2571-2575. (doi:10.1093/ndt/gfr694)

Emery, V.C. et al. (2012) Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. Journal of Clinical Virology, 54(1), pp. 56-60. (doi:10.1016/j.jcv.2012.01.015)

Lisboa, L.F., Tong, Y., Kumar, D., Pang, X.L., Åsberg, A., Hartmann, A., Rollag, H., Jardine, A.G., Pescovitz, M.D. and Humar, A. (2012) Analysis and clinical correlation of genetic variation in cytomegalovirus. Transplant Infectious Disease, 14(2), pp. 132-140. (doi:10.1111/j.1399-3062.2011.00685.x)

Soveri, I., Abedini, S., Holdaas, H., Jardine, A., Eriksson, N. and Fellström, B. (2012) Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial. Journal of Nephrology, 25(2), pp. 245-254. (doi:10.5301/JN.2011.8450)

Patel, R.K., Mark, P.B., Macnaught, G., Stevens, K.K., McQuarrie, E.P., Steedman, T., Gillis, K., Dargie, H.J. and Jardine, A.G. (2012) Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy. Nephrology Dialysis Transplantation, 27(6), pp. 2446-2451. (doi:10.1093/ndt/gfr688)

Rollag, H., Åsberg, A., Ueland, T., Hartmann, A., Jardine, A.G., Humar, A., Pescovitz, M.D., Bignamini, A.A. and Aukrust, P. (2012) Treatment of cytomegalovirus disease in solid organ transplant recipients. Transplantation, 94(10), pp. 1060-1065. (doi:10.1097/TP.0b013e31826c39de)

2011

Jardine, A.G., Gaston, R.S., Fellstrom, B.C. and Holdaas, H. (2011) Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet, 378(9800), pp. 1419-1427. (doi:10.1016/S0140-6736(11)61334-2)

Holdaas, H. et al. (2011) Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation, 92(4), pp. 410-418. (doi:10.1097/TP.0b013e318224c12d)

McQuarrie, E.P., Patel, R.K., Mark, P.B., Delles, C., Connell, J., Dargie, H.J., Steedman, T. and Jardine, A.G. (2011) Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 26(3), pp. 933-938. (doi:10.1093/ndt/gfq418)

Patel, R.K., Mark, P.B., Halliday, C., Steedman, T., Dargie, H. J., Cobbe, S.M. and Jardine, A.G. (2011) Microvolt T-Wave Alternans in End-Stage Renal Disease Patients--Associations with Uremic Cardiomyopathy. Clinical Journal of the American Society of Nephrology, 6(3), pp. 519-527. (doi:10.2215/CJN.06370710)

Stevens, K.K., Morgan, I.R., Patel, R.K., Geddes, C.C., Mark, P.B., Jardine, A.G. and Delles, C. (2011) Serum phosphate and outcome at one year after deceased donor renal transplantation. Clinical Transplantation, 25(2), E199-E204. (doi:10.1111/j.1399-0012.2011.01400.x)

Dahle, D. O. et al. (2011) Inflammation-associated graft loss in renal transplant recipients. Nephrology Dialysis Transplantation, 26(11), pp. 3756-3761. (doi:10.1093/ndt/gfr163)

Holdaas, H., Holme, I., Schmieder, R. E., Jardine, A.G., Zannad, F., Norby, G. E. and Fellstrom, B. C. (2011) Rosuvastatin in Diabetic Hemodialysis Patients. Journal of the American Society of Nephrology, 22(7), pp. 1335-1341. (doi:10.1681/ASN.2010090987)

Lisboa, L.F., Åsberg, A., Kumar, D., Pang, X., Hartmann, A., Preiksaitis, J.K., Pescovitz, M.D., Rollag, H., Jardine, A.G. and Humar, A. (2011) The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response. Transplantation, 91(2), pp. 231-236. (doi:10.1097/TP.0b013e3181ff8719)

McQuarrie, E.P., Shakerdi, L., Jardine, A.G., Fox, J.G. and Mackinnon, B. (2011) Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis. Nephrology Dialysis Transplantation, 26(5), pp. 1563-1569. (doi:10.1093/ndt/gfq605)

Payne, C.J., Gibson, S.C., Bryce, G., Jardine, A.G., Berry, C. and Kingsmore, D.B. (2011) B-type natriuretic peptide predicts long-term survival after major non-cardiac surgery. British Journal of Anaesthesia, 107(2), pp. 144-149. (doi:10.1093/bja/aer119)

Payne, C.J., Payne, A.R., Gibson, S.C., Jardine, A.G., Berry, C. and Kingsmore, D.B. (2011) Is there still a role for preoperative 12-lead electrocardiography? World Journal of Surgery, 35(12), pp. 2611-2616. (doi:10.1007/s00268-011-1289-y)

Stevens, K.K. and Jardine, A.G. (2011) SHARP: a stab in the right direction in chronic kidney disease. Lancet, 377(9784), pp. 2153-2154. (doi:10.1016/S0140-6736(11)60822-2)

Stevens, K.K., McQuarrie, E.P., Sands, W., Hillyard, D.Z., Patel, R.K., Mark, P.B. and Jardine, A.G. (2011) Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation. International Journal of Nephrology, 2011(297070), pp. 1-6. (doi:10.4061/2011/297070)

Åsberg, A., Jardine, A.G., Bignamini, A. A., Rollag, H., Gahlemann, C. C., Humar, A. and Hartmann, A. (2011) Response to Letter About Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease. American Journal of Transplantation, 11(5), pp. 1103-1104. (doi:10.1111/j.1600-6143.2011.03500.x)

2010

Holme, I., Fellstrom, B., Jardine, A. and Holdaas, H. (2010) Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients. Atherosclerosis, 208(1), pp. 234-239. (doi:10.1016/j.atherosclerosis.2009.06.020)

Blumberg, E.A., Hauser, I.A., Stanisic, S., Mueller, E., Berenson, K., Gahlemann, C.G., Humar, A. and Jardine, A.G. (2010) Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States. Transplantation, 90(12), pp. 1420-1426. (doi:10.1097/TP.0b013e3181ff500d)

Delles, C. and Jardine, A.G. (2010) Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes. Diabetologia, 54(1), pp. 4-6. (doi:10.1007/s00125-010-1942-2)

Edward, M., Quinn, J.A., Burden, A.D., Newton, B.B. and Jardine, A.G. (2010) Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Radiology, 256(3), pp. 735-743. (doi:10.1148/radiol.10091131)

Humar, A. et al. (2010) The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients. American Journal of Transplantation, 10(5), pp. 1228-1237. (doi:10.1111/j.1600-6143.2010.03074.x)

Humar, A., Limaye, A.P., Blumberg, E.A., Hauser, I.A., Vincenti, F., Jardine, A.G., Abramowicz, D., Ives, J.A.L., Farhan, M. and Peeters, P. (2010) Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study. Transplantation, 90(12), pp. 1427-1431. (doi:10.1097/TP.0b013e3181ff1493)

Mark, P. B., Patel, R. K. and Jardine, A. G. (2010) Screening for Coronary Artery Disease Before Renal Transplantation-Rational or Rationing? Transplantation, 89(7), pp. 807-808. (doi:10.1097/TP.0b013e3181cca6b6)

Patel, R.K., Jardine, A.G.M., Mark, P.B., Cunningham, A.F., Steedman, T., Powell, J.R., McQuarrie, E.P., Stevenson, K.K., Dargie, H.J. and Jardine, A.G. (2010) Association of left atrial volume with mortality among esrd patients with left ventricular hypertrophy referred for kidney transplant. American Journal of Kidney Diseases, 55(6), pp. 1088-1096. (doi:10.1053/j.ajkd.2009.12.033)

Stevens, K., Patel, R.K., Clancy, M. and Jardine, A.G. (2010) Angiotensin Blockade Is Associated With Early Graft Dysfunction After Live Donor Renal Transplantation. Transplantation, 89(6), pp. 707-709. (doi:10.1097/TP.0b013e3181c892f2)

Thomson, P. C., Collidge, T. A., Mark, P.B., Traynor, J.P., Jardine, A.G., Morris, S. T. W., Simpson, K. and Roditi, G. H. (2010) Correction to the Relative Risk Calculation for Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis Response. Radiology, 255(1), p. 308.

Åsberg, A., Jardine, A.G., Bignamini, A. A., Rollag, H., Pescovitz, M. D., Gahlemann, C. C., Humar, A. and Hartmann, A. (2010) Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients. American Journal of Transplantation, 10(8), pp. 1881-1888. (doi:10.1111/j.1600-6143.2010.03114.x)

2009

Patel, R., Oliver, S., Mark, P., Powell, J., McQuarrie, E., Traynor, J., Dargie, H. and Jardine, A. (2009) Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging. Clinical Journal of the American Society of Nephrology, 4(9), pp. 1477-1483. (doi:10.2215/CJN.03350509)

Wu, O., Levy, A.R., Briggs, A., Lewis, G. and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87(9), pp. 1330-1339. (doi:10.1097/TP.0b013e3181a236e0)

Mark, P. B., Jardine, A. G., Roditi, G. H. and Brady, A. J. (2009) Renal artery stenosis. In: Donnelly, R. and London, N. J. (eds.) ABC of Arterial and Venous Disease. Series: BMJ Books. Wiley-Blackwell: Oxford, pp. 37-43. ISBN 9781405178891

Asberg, A. et al. (2009) Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients. American Journal of Transplantation, 9(5), pp. 1205-1213.

Boivin, G., Goyette, N., Rollag, H., Jardine, A., Pescovitz, M., Asberg, A., Ives, J., Hortmann, A. and Humar, A. (2009) Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antiviral Therapy, 14(5), pp. 697-704.

Brown, M., Gaffney, D., Gemmell, C., Oakes, E., Morris, S., Spooner, R., Jardine, A. and Geddes, C. (2009) Hemochromatosis gene mutations and treatment of anemia in patients on hemodialysis. Hemodialysis International, 13(4), pp. 460-466.

Fellstrom, B., Holdaas, H., Jardine, A., Svensson, M., Gottlow, M., Schmieder, R. and Zannad, F. (2009) Cardiovascular disease in patients with renal disease: the role of statins. Current Medical Research and Opinion, 25(1), pp. 271-285.

Fellstrom, B., Jardine, A. and Holdaas, H. (2009) Rosuvastatin in Patients Undergoing Hemodialysis REPLY. New England Journal of Medicine, 361(1), pp. 94-95.

Fellstrom, B. et al. (2009) Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis. New England Journal of Medicine, 360(14), pp. 1395-1407. (doi:10.1056/NEJMoa0810177)

Humar, A., Asberg, A., Kumar, D., Hartmann, A., Moussa, G., Jardine, A., Rollag, H., Mouas, H., Gahlemann, C. and Pescovitz, M. (2009) An Assessment of Herpesvirus Co-infections in Patients with CMV Disease: Correlation with Clinical and Virologic Outcomes. American Journal of Transplantation, 9(2), pp. 374-381.

Jardine, A. G., Mark, P. B., Holdaas, H. and Fellstrøm, B. (2009) Special patient populations: chronic renal disease. In: Ballantyne, C. M. (ed.) Lipidology: A Companion To Braunwald's Heart Disease. Elsevier: Oxford, pp. 500-508. ISBN 9781416054696

Manuel, O. et al. (2009) Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid-Organ Transplant Recipients with Cytomegalovirus Disease. Clinical Infectious Diseases, 49(8), pp. 1160-1166.

Powell, J., Oluwaseun, O., Woo, Y., Padmanabhan, N., Narasinghan, E., Latta, C., Tortolano, J., Jardine, A. and Geddes, C. (2009) Ten Years Experience of In-Center Thrice Weekly Long Overnight Hemodialysis. Clinical Journal of the American Society of Nephrology, 4(6), pp. 1097-1101.

2008

Patel, R., Mark, P., Johnston, N., McGeoch, R., Lindsay, M., Dargie, H. and Jardine, A. (2008) Cardiovascular screening of potential renal transplant recipients provides no survival benefit. American Journal of Transplantation, 8(s2), pp. 597-598. (doi:10.1111/j.1600-6143.2008.02255.x)

Edward, M., Quinn, J.A., Mukherjee, S., Jensen, M.B., Jardine, A.G., Mark, P. and Burden, A. (2008) Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. Journal of Pathology, 214(5), pp. 584-593. (doi:10.1002/path.2311)

Doyle, A., Mark, P.B., Johnston, N., Foster, J., Connell, J., Dargie, H., Jardine, A. and Padmanabhan, N. (2008) Aortic stiffness and diastolic flow abnormalities in end-stage renal disease assessed by magnetic resonance imaging. Nephron Clinical Practice, 109(1), C1-C8. (doi:10.1159/000130170)

Mackinnon, B., Padmanabhan, S., Murray, L., Sloan, W., Meredith, P., Reid, J., Walters, M., Jardine, A., Simpson, K. and McInnes, G. (2008) Is end stage renal disease a common outcome among patients attending a hypertension clinic? Journal of Hypertension, 26, S112-S112.

Mark, P., Doyle, A., Blyth, K., Patel, R., Weir, R., Steedman, T., Foster, J., Dargie, H. and Jardine, A. (2008) Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. Journal of Cardiovascular Magnetic Resonance, 10(39), (doi:10.1186/1532-429X-10-39)

McDonald, K. and Jardine, A. (2008) The use of fluvastatin in cardiovascular risk management. Expert Opinion on Pharmacotherapy, 9(8), pp. 1407-1414.

O'Connor, S., Jardine, A. and Millar, K. (2008) The prediction of self-care behaviors in end-stage renal disease patients using Leventhal's Self-Regulatory Model. Journal of Psychosomatic Research, 65(2), pp. 191-200. (doi:10.1016/j.jpsychores.2008.02.008)

Patel, R.K., Mark, P.B., Johnston, N., McGeoch, R., Lindsay, M., Kingsmore, D.B., Dargie, H.J. and Jardine, A.G. (2008) Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. American Journal of Transplantation, 8(8), pp. 1673-1683. (doi:10.1111/j.1600-6143.2008.02281.x)

Patel, R., Mark, P., Johnston, N., McGregor, E., Dargie, H. and Jardine, A. (2008) Renal Transplantation Is Not Associated with Regression of Left Ventricular Hypertrophy: A Magnetic Resonance Study. Clinical Journal of the American Society of Nephrology, 3(6), pp. 1807-1811. (doi:10.2215/CJN.01400308)

2007

Murphy, C.L., Fitzsimons, E.J., Jardine, A.J., Sattar, N. and McMurray, J.J.V. (2007) 103 routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia. European Journal of Heart Failure, 6(1), p. 24. (doi:10.1016/s1567-4215(07)60065-4)

Mark, P. B., Petrie, C. J. and Jardine, A. G. (2007) Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Seminars in Dialysis, 20, pp. 40-49. (doi:10.1111/j.1525-139X.2007.00240.x)

Asberg, A., Humar, A., Rollag, H., Jardine, A., Mouas, H., Pescovitz, M., Sgarabotto, D., Tuncer, M., Noronha, I. and Hartmann, A. (2007) Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. American Journal of Transplantation, 7, pp. 2106-2113. (doi:10.1111/j.1600-6143.2007.01910.x)

Collidge, T., Jardine, A., Mark, P., Morris, S., Roditi, G., Simpson, K., Thomson, P. and Traynor, J. (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort. Radiology, 245(1), pp. 168-175.

Dawes, H.A., Docherty, T., Traynor, I., Gilmore, D.H., Jardine, A.G. and Knill-jones, R. (2007) Specialist nurse supported discharge in gynaecology: A randomised comparison and economic evaluation. European Journal of Obstetrics and Gynecology and Reproductive Biology, 130(2), pp. 262-270.

Fellstrom, B., Holdaas, H., Jardine, A., Rose, H., Schmieder, R., Wilpshaar, W. and Zannad, F. (2007) Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney and Blood Pressure Research, 30, pp. 314-322. (doi:10.1159/000106803)

Gardner, R., Chong, K., O'Meara, E., Jardine, A., Ford, I. and McDonagh, T. (2007) Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. European Heart Journal, 28(24), pp. 3027-3033.

Hillyard, D., Nutt, C., Thomson, J., McDonald, K., Wan, R., Cameron, A., Mark, P. and Jardine, A. (2007) Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis, 191, pp. 319-325. (doi:10.1016/j.atherosclerosis.2006.05.037)

Joss, N., Staatz, C., Thomson, A. and Jardine, A. (2007) Predictors of new onset diabetes after renal transplantation. Clinical Transplantation, 21, pp. 136-143. (doi:10.1111/j.1399-0012.2006.00580.x)

Mark, P. B., Patel, R. K. and Jardine, A. G. (2007) Are we overestimating left ventricular abnormalities in end-stage renal disease? Nephrology Dialysis Transplantation, 22(7), pp. 1815-1819. (doi:10.1093/ndt/gfm224)

Oppenheimer, F. et al. (2007) Impact of long-term therapy with FTY720 or mycophenolate mofetil on cardiac conduction and rhythm in stable adult renal transplant patients. Transplantation, 83(5), pp. 645-648.

Singer, J., Holdaas, H., Jardine, A., Fellstrom, B., Os, I., Bermann, G. and Meyer, J. (2007) Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients. Journal of Lipid Research, 48, pp. 2072-2078. (doi:10.1194/jlr.M700076-JLR200)

Wan, R., Mark, P. and Jardine, A. (2007) The cholesterol paradox is flawed; Cholesterol must be lowered in dialysis patients. Seminars in Dialysis, 20, pp. 504-509. (doi:10.1111/j.1525-139X.2007.00359.x)

Zimmerli, L., Mark, P., Steedman, T., Foster, J., Berg, G., Dargie, H., Jardine, A., Delles, C. and Dominiczak, A. (2007) Vascular function in patients with end-stage renal disease and/or coronary artery disease: A cardiac magnetic resonance imaging study. Kidney International, 71(1), pp. 68-73. (doi:10.1038/sj.ki.5002024)

2006

Wan, R. K., Mark, P. B. and Jardine, A. G. (2006) Cardiovascular disease management in renal transplant recipients: more or less treatment? Transplantation, 82(6), pp. 737-738. (doi:10.1097/01.tp.0000235431.71677.e3)

Mark, P.B. and Jardine, A.G. (2006) Cardiovascular magnetic resonance imaging has much to offer in the assessment of renal transplant recipients. American Journal of Transplantation, 6(8), pp. 1975-1976. (doi:10.1111/j.1600-6143.2006.01376.x)

Fellstrom, B., Abedini, S., Holdaas, H., Jardine, A., Staffler, B., Gimpelewicz, C. and ALERT Study Grp, (2006) No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study. Clinical Transplantation, 20, pp. 732-739. (doi:10.1111/j.1399-0012.2006.00555.x)

Mark, P.B., Johnston, N., Groenning, B.A., Foster, J.E., Blyth, K., Martin, T.N., Steedman, T., Dargie, H.J. and Jardine, A.G. (2006) Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney International, 69(10), pp. 1839-1845. (doi:10.1038/sj.ki.5000249)

Mark, P., Stewart, G., Gansevoort, R., Petrie, C., McDonagh, T., Dargie, H., Rodger, R. and Jardine, A. (2006) Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrology Dialysis Transplantation, 21, pp. 402-410. (doi:10.1093/ndt/gfi187)

O'Meara, E., Chong, K., Gardner, R., Jardine, A., Neilly, J. and McDonagh, T. (2006) The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. European Journal of Heart Failure, 8(1), pp. 63-67. (doi:10.1016/j.ejheart.2005.04.013)

Oien, C., Reisaeter, A., Os, I., Jardine, A., Fellstrom, B. and Holdaas, H. (2006) Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study. Clinical Transplantation, 20, pp. 374-382. (doi:10.1111/j.1399-0012.2006.00496.x)

Soveri, I., Holdaas, H., Jardine, A., Gimpelewicz, C., Staffler, B. and Fellstrom, B. (2006) Renal transplant dysfunction - importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality. Nephrology Dialysis Transplantation, 21, pp. 2282-2289. (doi:10.1093/ndt/gfl095)

Wan, R. and Jardine, A. (2006) The impact and treatment of obesity and dyslipidaemias in renal transplantation. Current Opinion in Organ Transplantation, 11, pp. 401-406.

2005

Mark, P.B., Murphy, K., Mohammed, A.S., Morris, S.T.W. and Jardine, A.G. (2005) Endothelial dysfunction in renal transplant recipients. Transplantation Proceedings, 37(9), pp. 3805-3807. (doi:10.1016/j.transproceed.2005.09.116)

Fellstrom, B., Zannad, F., Schmieder, R., Holdaas, H., Jardine, A., Rose, H. and Wilspshaar, W. (2005) Effect of rosuvastatin on outcomes in chronic haemodialysis patients - Design and rationale of the AURORA study. Current Controlled Trials in Cardiovascular Medicine, 6, p. 9. (doi:10.1186/1468-6708-6-9)

Tutone, V.K., Mark, P.B., Stewart, G.A., Tan, C.C., Rodger, R.S.C., Geddes, C.C. and Jardine, A.G. (2005) Hypertension, antihypertensive agents and outcomes following renal transplantation. Clinical Transplantation, 19(2), pp. 181-192. (doi:10.1111/j.1399-0012.2004.00315.x)

Stewart, G., Gansevoort, R., Mark, P., Rooney, E., McDonagh, T., Dargie, H., Stuart, R., Rodger, C. and Jardine, A. (2005) Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney International, 67(1), pp. 217-226. (doi:10.1111/j.1523-1755.2005.00072.x)

Fellstrom, B. et al. (2005) Risk factors for reaching renal Endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) trial. Transplantation, 79, pp. 205-212. (doi:10.1097/01.TP.0000147338.34323.12)

Fellstrom, B. et al. (2005) Effect of rosuvastatin on outcomes in chronic haemodialysis patients - Design and rationale of the AURORA study. Current Controlled Trials in Cardiovascular Medicine, 6(9), (doi:10.1159%2F000106803)

Holdaas, H. et al. (2005) Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. American Journal of Transplantation, 5, pp. 2929-2936. (doi:10.1111/j.1600-6143.2005.01105.x)

Holdaas, H. et al. (2005) Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrology Dialysis Transplantation, 20, pp. 974-980. (doi:10.1093/ndt/gfh735)

Jardine, A. (2005) Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transplant International, 18, pp. 379-384. (doi:10.1111/j.1432-2277.2005.00080.x)

Jardine, A. et al. (2005) Cardiovascular risk and renal transplantation: Post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) study. American Journal of Kidney Diseases, 46, pp. 529-536. (doi:10.1053/j.ajkd.2005.05.014)

Joss, N., Jardine, A., Gaffney, D. and Boulton-Jones, J. (2005) Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Experimental Nephrology, 101, E127-E133. (doi:10.1159/000087577)

McLean, D. and Jardine, A. (2005) A simulation model to investigate the impact of cardiovascular risk in renal transplantation. Transplantation Proceedings, 37, pp. 2135-2143. (doi:10.1016/j.transproceed.2005.03.057)

Mohamed, A., Thomson, J., McDonald, K., Hillyard, D., Mark, P., Elliott, H. and Jardine, A. (2005) Circulating endothelial cells in renal transplant recipients. Transplantation Proceedings, 37, pp. 2387-2390. (doi:10.1016/j.transproceed.2005.03.126)

Wilkinson, A. et al. (2005) Guidelines for the treatment and management of new-onset diabetes after transplantation. Clinical Transplantation, 19, pp. 291-298. (doi:10.1111/j.1399-0012.2005.00359.x)

2004

Tutone, V.K., Mark, P.B., Revanur, V., Traynor, J., Buist, L.J., Geddes, C.C., Deardon, D. and Jardine, A.G. (2004) Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplantation Proceedings, 36(10), pp. 3006-3011. (doi:10.1016/j.transproceed.2004.10.067)

Hillyard, D.Z., Cameron, A.J.M., McDonald, K.J., Thomson, J., MacIntyre, A., Shiels, P.G., Panarelli, M. and Jardine, A.G. (2004) Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease. Atherosclerosis, 175(2), pp. 305-313. (doi:10.1016/j.atherosclerosis.2004.03.018)

Cowan, M., Dargie, H., Foster, J., Jardine, A., Johnston, N., Mark, P., Rodger, R. and Stewart, G. (2004) Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clinical Physiology and Functional Imaging, 24, pp. 387-393.

Hillyard, D., Jardine, A., McDonald, K. and Cameron, A. (2004) Fluvastatin inhibits raft dependent Fc gamma receptor signalling in human monocytes. Atherosclerosis, 172, pp. 219-228. (doi:10.1016/j.atherosclerosis.2003.11.004)

Jardine, A. and Geddes, C. (2004) Cyclosporine in renal transplantation: A Scottish experience. Transplantation Proceedings, 36, 139S-142S. (doi:10.1016/j.transproceed.2003.12.052)

Jardine, A. et al. (2004) Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT study. American Journal of Transplantation, 4, pp. 988-995. (doi:10.1111/j.1600-6143.2004.00445.x)

McDonald, K., McMillan, M., Rodger, R., Junor, B., Geddes, C., Briggs, J. and Jardine, A. (2004) Persistent dipstick haematuria following renal transplantation. Clinical Transplantation, 18, pp. 321-326.

2003

Stanton, T., Payne, J.R., Montgomery, H.E., Watt, G., Dominiczak, A.F., Jardine, A.G. and Connell, J.M. (2003) Genetic determinants of left ventricular mass: the role of beta-1 adrenoceptor variation in normal, athletic, and disease populations. Journal of the American College of Cardiology, 41(6 (S1)), p. 273. (doi:10.1016/S0735-1097(03)82282-9)

Asberg, A., Holdaas, H., Jardine, A., Edvardsen, C. and Hartmann, A. (2003) Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation. Clinical Transplantation, 17, pp. 385-390.

Crilly, A., Hamilton, J., Clark, C., Jardine, A. and Madhok, R. (2003) Analysis of the 5 ' flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology, 42, pp. 1295-1298. (doi:10.1093/rheumatology/keg420)

Geddes, C., Rauta, V., Gronhagen-Riska, C., Bartosik, L., Jardine, A., Ibels, L., Pei, Y. and Cattran, D. (2003) A tricontinental view of IgA nephropathy. Nephrology Dialysis Transplantation, 18, pp. 1541-1548. (doi:10.1093/ndt.gfg207)

Holdaas, H. et al. (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet, 361, pp. 2024-2031.

Joosten, S.A., van Ham, V., Nolan, C.E., Borrias, M.C., Jardine, A.G., Shiels, P.G., van Kooten, C. and Paul, L.C. (2003) Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. American Journal of Pathology, 162(4), pp. 1305-1312. (doi:10.1016/S0002-9440(10)63926-0)

2002

Crilly, A., Hamilton, J., Clark, C., Jardine, A. and Madhok, R. (2002) Analysis of transforming growth factor beta 1 gene polymorphisms in patients with systemic sclerosis. Annals of the Rheumatic Diseases, 61, pp. 678-681.

Geddes, C., Woo, Y. and Jardine, A. (2002) The impact of delayed graft function on the long-term outcome of renal transplantation. Journal of Nephrology, 15, pp. 17-21.

Hillyard, D., Cameron, A., McIntyre, A., Hadden, M., Marshall, H., Johnston, N. and Jardine, A. (2002) Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin. Clinical and Experimental Pharmacology and Physiology, 29, pp. 673-678.

McDonald, K., Cameron, A., Allen, J. and Jardine, A. (2002) Expression of Fc alpha/mu receptor by human mesangial cells: A candidate receptor for immune complex deposition in IgA nephropathy. Biochemical and Biophysical Research Communications, 290, pp. 438-442. (doi:10.1006/bbrc.2001.6218)

Stanton, T., Inglis, G.C., Padmanabhan, S., Dominiczak, A.F., Jardine, A.G. and Connell, J.M. (2002) Variation at the beta-1 adrenoceptor gene locus affects left ventricular mass in renal failure. Journal of Nephrology, 15(5), pp. 512-518.

Woo, Y. et al. (2002) The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation. Journal of Nephrology, 15, pp. 380-386.

2001

Joseph, J., Kingsmore, D., Junior, B., Briggs, J., Woo, Y., Jaques, B., Hamilton, D., Jardine, A. and Jindal, R. (2001) The impact of late acute rejection after cadaveric kidney transplantation. Clinical Transplantation, 15, pp. 221-227.

Morris, S., McMurray, J., Spiers, A. and Jardine, A. (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney International, 60, pp. 1077-1082.

Revanur, V., Jardine, A., Kingsmore, D., Jaques, B., Hamilton, D. and Jindal, R. (2001) Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clinical Transplantation, 15, pp. 89-94.

2000

Morris, S. T.W., McMurray, J. J.V. , Rodger, R. S. C., Farmer, R. and Jardine, A. G. (2000) Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney International, 57(3), pp. 1100-1106. (doi:10.1046/j.1523-1755.2000.00937.x) (PMID:10720962)

1999

Morris, S.T.W., McMurray, J.J.V. , Rodger, R.S.C., Briggs, J.D. and Jardine, A.G. (1999) Impaired vascular responsiveness to nitric oxide in renal transplant recipients. Transplantation Proceedings, 31(1-2), pp. 304-305. (doi:10.1016/s0041-1345(98)01637-6) (PMID:10083118)

1992

Northridge, D. B., Jamieson, M. P., Jardine, A. G., MacArthur, K. J.D., MacFarlane, N. and Dargie, H. J. (1992) Pulmonary extraction and left atrial secretion of atrial natriuretic factor during cardiopulmonary bypass surgery. American Heart Journal, 123(3), pp. 698-703. (doi:10.1016/0002-8703(92)90509-T) (PMID:1531724)

This list was generated on Tue Jul 25 19:23:35 2017 BST.
Number of items: 168.

Articles

Rutherford, E., Stewart, G., Houston, J. G., Jardine, A. G. , Mark, P. B. and Struthers, A. D. (2017) An open-label dose-finding study of allopurinol to target defined reduction in urate levels in hemodialysis patients. Journal of Clinical Pharmacology, (doi:10.1002/jcph.939) (PMID:28597919) (Early Online Publication)

Holdaas, H., Mjøen, G. and Jardine, A. G. (2017) Belatacept: where the BENEFITS outweigh the risk. American Journal of Kidney Diseases, 69(5), pp. 561-563. (doi:10.1053/j.ajkd.2017.02.007) (PMID:28434523)

Rose, J., Emery, V. C., Kumar, D., Asberg, A., Hartmann, A., Jardine, A. G. , Bignamini, A. A., Humar, A. and Neumann, A. U. (2017) Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection. PLoS Pathogens, 13(4), e1006299. (doi:10.1371/journal.ppat.1006299) (PMID:28406982) (PMCID:PMC5391089)

Neuberger, J. M. et al. (2017) Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) group. Transplantation, 101(4 S2), S1-S56. (doi:10.1097/TP.0000000000001651) (PMID:28328734)

Fellström, B. C. et al. (2017) Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet, (doi:10.1016/S0140-6736(17)30550-0) (In Press)

Rutherford, E., Weir-McCall, J. R., Patel, R. K., Houston, J. G., Roditi, G., Struthers, A. D., Jardine, A. G. and Mark, P. B. (2017) Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings. European Radiology, 27(1), pp. 315-324. (doi:10.1007/s00330-016-4288-4) (PMID:27053260)

Solbu, M. D., Mjøen, G., Mark, P. B. , Holdaas, H., Fellström, B., Schmieder, R. E., Zannad, F., Herrington, W. G. and Jardine, A. (2016) Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA Study. Nephrology Dialysis Transplantation, (doi:10.1093/ndt/gfw360) (PMID:27798199) (Early Online Publication)

Rutherford, E. et al. (2016) Definition of myocardial tissue abnormalities in end stage renal failure with cardiac magnetic resonance imaging using T1 mapping. Kidney International, 90(4), pp. 845-852. (doi:10.1016/j.kint.2016.06.014)

Currie, G. et al. (2016) Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrology, 17, 127. (doi:10.1186/s12882-016-0337-0) (PMID:27609359) (PMCID:PMC5015203)

Findlay, M. D. et al. (2016) Risk factors and outcome of stroke in renal transplant recipients. Clinical Transplantation, 30(8), pp. 918-924. (doi:10.1111/ctr.12765) (PMID:27218240)

Herrington, W. G. et al. (2016) Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. Lancet Diabetes and Endocrinology, 4(10), pp. 829-839. (doi:10.1016/S2213-8587(16)30156-5) (PMID:27477773)

Stevens, K., Denby, L., Patel, R. K., Mark, P. B. , Kettlewell, S., Smith, G. L. , Clancy, M. J., Delles, C. and Jardine, A. G. (2016) Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway. Nephrology Dialysis Transplantation, (doi:10.1093/ndt/gfw252) (PMID:27448672) (Early Online Publication)

Solbu, M. D. and Jardine, A. G. (2016) ‘To block or not to block’; whether to continue renin–angiotensin–aldosterone system blockade in advanced chronic kidney disease. Nephrology Dialysis Transplantation, 31(2), pp. 171-173. (doi:10.1093/ndt/gfv351) (PMID:26445812)

Solbu, M. D., Thomson, P. C., Macpherson, S., Findlay, M. D., Stevens, K. K., Patel, R. K., Padmanabhan, S. , Jardine, A. G. and Mark, P. B. (2015) Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease. BMC nephrology, 16(1), 194. (doi:10.1186/s12882-015-0187-1) (PMID:26627078) (PMCID:PMC4666082)

Patel, R., Jeemon, P., Stevens, K., Mccallum, L., Hastie, C., Schneider, A., Jardine, A. , Mark, P. and Padmanabhan, S. (2015) Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults. Journal of Hypertension, 33(10), pp. 2046-2053. (doi:10.1097/hjh.0000000000000659) (PMID:26431193)

Findlay, M. D., Thomson, P. C., Fulton, R. L., Solbu, M. D., Jardine, A. G. , Patel, R. K., Stevens, K. K., Geddes, C. C., Dawson, J. and Mark, P. B. (2015) Risk factors of ischemic stroke and subsequent outcome in hemodialysis patients. Stroke, 46(9), pp. 2477-2481. (doi:10.1161/STROKEAHA.115.009095) (PMID:26230856)

Lees, J. S., Mark, P. B. and Jardine, A. G. (2015) Cardiovascular complications of chronic kidney disease. Medicine, 43(8), pp. 469-473. (doi:10.1016/j.mpmed.2015.05.009)

Drechsler, C. et al. (2015) Homoarginine and clinical outcomes in renal transplant recipients. Transplantation, 99(7), pp. 1470-1476. (doi:10.1097/tp.0000000000000568) (PMID:25675199)

Oliver, S.W., Thomson, P.C. and Jardine, A.G. (2015) Safe central venous catheter insertion practice must extend beyond simply measuring catheter-associated bloodstream infections. Journal of Hospital Infection, 90(1), p. 81. (doi:10.1016/j.jhin.2014.11.021) (PMID:25617090)

Stoumpos, S., Jardine, A. G. and Mark, P. B. (2015) Cardiovascular morbidity and mortality after kidney transplantation. Transplant International, 28(1), pp. 10-21. (doi:10.1111/tri.12413) (PMID:25081992)

Ueland, T., Rollag, H., Hartmann, A., Jardine, A., Humar, A., Bignamini, A. A., Åsberg, A. and Aukrust, P. (2015) Increased osteoprotegerin predicts poor virological outcome during anticytomegalovirus therapy in solid organ transplant recipients. Transplantation, 99(1), pp. 100-105. (doi:10.1097/TP.0000000000000227)

Jardine, A. G. (2015) Con: Ambulatory blood pressure measurement in patients receiving haemodialysis: a sore arm and a waste of time? Nephrology Dialysis Transplantation, 30(9), pp. 1438-1441. (doi:10.1093/ndt/gfv244) (PMID:26022726) (PMCID:26022726)

Jardine, A. G. (2015) Opponent's comments. Nephrology Dialysis Transplantation, 30(9), pp. 1437-1438. (doi:10.1093/ndt/gfv243a) (PMID:26311657)

So, B. H., Methven, S., Hair, M. D., Jardine, A. G. and MacGregor, M. S. (2015) Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis. Nephrology Dialysis Transplantation, 30(6), pp. 1010-1017. (doi:10.1093/ndt/gfu408) (PMID:25586406)

Hirsch, H.H. et al. (2014) European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clinical Microbiology and Infection, 20(Sup 7), pp. 74-88. (doi:10.1111/1469-0691.12538)

Sharif, A. et al. (2014) Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. American Journal of Transplantation, 14(9), pp. 1992-2000. (doi:10.1111/ajt.12850)

Holdaas, H. and Jardine, A. G. (2014) BP targets in renal transplant recipients: too high or too low? Journal of the American Society of Nephrology, 25(7), pp. 1371-1373. (doi:10.1681/ASN.2014020177)

Mark, P. B., Taylor, A. H. M., McQuarrie, E. P. and Jardine, A. G. (2014) How is the heart best protected in chronic dialysis patients? Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients. Seminars in Dialysis, 27(4), pp. 328-332. (doi:10.1111/sdi.12178)

McQuarrie, E. P., Traynor, J. P., Taylor, A. H., Freel, E. M., Fox, J. G., Jardine, A. G. and Mark, P. (2014) Association between urinary sodium, creatinine, albumin, and long term survival in chronic kidney disease. Hypertension, 64(1), pp. 111-117. (doi:10.1161/HYPERTENSIONAHA.113.03093)

Gillis, K. A., Patel, R. K. and Jardine, A. G. (2014) Cardiovascular complications after transplantation: treatment options in solid organ recipients. Transplantation Reviews, 28(2), pp. 47-55. (doi:10.1016/j.trre.2013.12.001)

Fellstrom, B., Holdaas, H. and Jardine, A. (2014) Functional cardiopulmonary exercise testing in potential renal transplant recipients. Journal of the American Society of Nephrology, 25(1), pp. 8-9. (doi:10.1681/ASN.2013090996)

Pihlstrøm, H., Mjøen, G., März, W., Olav Dahle, D., Abedini, S., Holme, I., Fellström, B., Jardine, A., Pilz, S. and Holdaas, H. (2014) Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients. Clinical Transplantation, 28(1), pp. 111-119. (doi:10.1111/ctr.12285) (PMID:24372612) (PMCID:PMC4204514)

Ueland, T., Rollag, H., Hartmann, A., Jardine, A.G., Humar, A., Michelsen, A.E., Bignamini, A.A., Åsberg, A. and Aukrust, P. (2014) Secreted wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients. American Journal of Transplantation, 14(1), pp. 210-215. (doi:10.1111/ajt.12506)

Gillis, K.A. et al. (2014) Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla. BMC Nephrology, 15(23), (doi:10.1186/1471-2369-15-23)

Schjelderup, P., Dahle, D.O., Holdaas, H., Mjøen, G., Nordby, G., Abedini, S., Jardine, A., Fellström, B. and Svensson, M. (2013) Anemia is a predictor of graft loss but not cardiovascular events and all-cause mortality in renal transplant recipients: follow-up data from the ALERT study. Clinical Transplantation, 27(6), E636-E643. (doi:10.1111/ctr.12220)

Patel, R.K., Taylor, A. and Jardine, A.G. (2013) Prophylactic ciprofloxacin for kidney transplant recipients—to add or not to add. Transplantation, 96(4), pp. 370-371. (doi:10.1097/TP.0b013e31829e2723)

Stevens, K.K., Patel, R.K., Methven, S., Clancy, M.J., Fox, J.G., Jardine, A.G. and Geddes, C.C. (2013) Proteinuria and outcome after renal transplantation. Transplantation, 96(1), pp. 65-69. (doi:10.1097/TP.0b013e318295852c)

McQuarrie, E.P., Freel, E.M., Mark, P.B. , Fraser, R., Connell, J.M.C. and Jardine, A.G. (2013) Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 28(6), pp. 1526-1532. (doi:10.1093/ndt/gft007)

Patel, R.K., Stevens, K.K. and Jardine, A.G. (2013) Sleep apnoea and the potential benefits of a good night's sleep in patients receiving maintenance dialysis. Nephrology Dialysis Transplantation, 28(4), pp. 777-778. (doi:10.1093/ndt/gfs532)

Brennan, D.C., Aguado, J.M., Potena, L., Jardine, A.G., Legendre, C., Säemann, M.D., Mueller, N.J., Merville, P., Emery, V. and Nashan, B. (2013) Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Reviews in Medical Virology, 23(2), pp. 97-125. (doi:10.1002/rmv.1733)

Schneider, A., Jardine, A.G., Schneider, M.P., Holdaas, H., Holme, I., Fellstroem, B.C., Zannad, F. and Schmieder, R.E. (2013) Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study. American Journal of Nephrology, 37(2), pp. 144-151. (doi:10.1159/000346710)

Holme, I., Fellstrom, B.C., Jardine, A.G., Hartmann, A. and Holdaas, H. (2013) Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients. Clinical Journal of the American Society of Nephrology, 8(2), pp. 241-247. (doi:10.2215/CJN.03760412)

Soveri, I., Snyder, J., Holdaas, H., Holme, I., Jardine, A.G., L’Italien, G.J. and Fellström, B. (2013) The external validation of the cardiovascular risk equation for renal transplant recipients. Transplantation, 95(1), pp. 142-147. (doi:10.1097/TP.0b013e31827722c9)

Dawson, J. et al. (2013) Serum uric acid level, longitudinal blood pressure, renal function, and long-term mortality in treated hypertensive patients. Hypertension, 62(1), pp. 105-111. (doi:10.1161/HYPERTENSIONAHA.113.00859)

Schneider, A., Schneider, M.P., Scharnagl, H., Jardine, A.G., Wanner, C. and Drechsler, C. (2013) Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes. BMC Nephrology, 14(67), (doi:10.1186/1471-2369-14-67)

Tonelli, M.A. et al. (2013) Introduction: the case for updating and context. Kidney International Supplements, 3(3), pp. 266-267. (doi:10.1038/kisup.2013.32)

Holdaas, H. and Jardine, A. (2012) Chronic kidney disease: do patients with CKD benefit from lipid-lowering therapy? Nature Reviews Nephrology, 8(12), pp. 684-685. (doi:10.1038/nrneph.2012.240)

Freel, E. M., Mark, P. B., Weir, R. A.P., McQuarrie, E. P., Allan, K., Dargie, H. J., McClure, J. D., Jardine, A. G., Davies, E. and Connell, J. M.C. (2012) Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circulation: Cardiovascular Imaging, 5(6), pp. 740-747. (doi:10.1161/CIRCIMAGING.112.974576)

Velasco, N. et al. (2012) Optimal fluid control can normalize cardiovascular risk markers and limit left ventricular hypertrophy in thrice weekly dialysis patients. Hemodialysis International, 16(4), pp. 465-472. (doi:10.1111/j.1542-4758.2012.00689.x)

McQuarrie, E. P., Freel, E. M., Mark, P. B., Fraser, R., Patel, R. K., Dargie, H. G., Connell, J. M. C. and Jardine, A. G. (2012) Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease. Clinical Science, 123(5), pp. 285-294. (doi:10.1042/CS20120015)

Soveri, I., Holme, I., Holdaas, H., Budde, K., Jardine, A.G. and Fellström, B. (2012) A cardiovascular risk calculator for renal transplant recipients. Transplantation, 94(1), pp. 57-62. (doi:10.1097/TP.0b013e3182516cdc)

Svensson, M., Dahle, D.O., Mjoen, G., Weihrauch, G., Marz, W., Jardine, A., Fellstrom, B. and Holdaas, H. (2012) Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. Nephrology Dialysis Transplantation, 27(6), pp. 2571-2575. (doi:10.1093/ndt/gfr694)

Emery, V.C. et al. (2012) Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. Journal of Clinical Virology, 54(1), pp. 56-60. (doi:10.1016/j.jcv.2012.01.015)

Lisboa, L.F., Tong, Y., Kumar, D., Pang, X.L., Åsberg, A., Hartmann, A., Rollag, H., Jardine, A.G., Pescovitz, M.D. and Humar, A. (2012) Analysis and clinical correlation of genetic variation in cytomegalovirus. Transplant Infectious Disease, 14(2), pp. 132-140. (doi:10.1111/j.1399-3062.2011.00685.x)

Soveri, I., Abedini, S., Holdaas, H., Jardine, A., Eriksson, N. and Fellström, B. (2012) Graft loss risk in renal transplant recipients with metabolic syndrome: subgroup analyses of the ALERT trial. Journal of Nephrology, 25(2), pp. 245-254. (doi:10.5301/JN.2011.8450)

Patel, R.K., Mark, P.B., Macnaught, G., Stevens, K.K., McQuarrie, E.P., Steedman, T., Gillis, K., Dargie, H.J. and Jardine, A.G. (2012) Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy. Nephrology Dialysis Transplantation, 27(6), pp. 2446-2451. (doi:10.1093/ndt/gfr688)

Rollag, H., Åsberg, A., Ueland, T., Hartmann, A., Jardine, A.G., Humar, A., Pescovitz, M.D., Bignamini, A.A. and Aukrust, P. (2012) Treatment of cytomegalovirus disease in solid organ transplant recipients. Transplantation, 94(10), pp. 1060-1065. (doi:10.1097/TP.0b013e31826c39de)

Jardine, A.G., Gaston, R.S., Fellstrom, B.C. and Holdaas, H. (2011) Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet, 378(9800), pp. 1419-1427. (doi:10.1016/S0140-6736(11)61334-2)

Holdaas, H. et al. (2011) Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study. Transplantation, 92(4), pp. 410-418. (doi:10.1097/TP.0b013e318224c12d)

McQuarrie, E.P., Patel, R.K., Mark, P.B., Delles, C., Connell, J., Dargie, H.J., Steedman, T. and Jardine, A.G. (2011) Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease. Nephrology Dialysis Transplantation, 26(3), pp. 933-938. (doi:10.1093/ndt/gfq418)

Patel, R.K., Mark, P.B., Halliday, C., Steedman, T., Dargie, H. J., Cobbe, S.M. and Jardine, A.G. (2011) Microvolt T-Wave Alternans in End-Stage Renal Disease Patients--Associations with Uremic Cardiomyopathy. Clinical Journal of the American Society of Nephrology, 6(3), pp. 519-527. (doi:10.2215/CJN.06370710)

Stevens, K.K., Morgan, I.R., Patel, R.K., Geddes, C.C., Mark, P.B., Jardine, A.G. and Delles, C. (2011) Serum phosphate and outcome at one year after deceased donor renal transplantation. Clinical Transplantation, 25(2), E199-E204. (doi:10.1111/j.1399-0012.2011.01400.x)

Dahle, D. O. et al. (2011) Inflammation-associated graft loss in renal transplant recipients. Nephrology Dialysis Transplantation, 26(11), pp. 3756-3761. (doi:10.1093/ndt/gfr163)

Holdaas, H., Holme, I., Schmieder, R. E., Jardine, A.G., Zannad, F., Norby, G. E. and Fellstrom, B. C. (2011) Rosuvastatin in Diabetic Hemodialysis Patients. Journal of the American Society of Nephrology, 22(7), pp. 1335-1341. (doi:10.1681/ASN.2010090987)

Lisboa, L.F., Åsberg, A., Kumar, D., Pang, X., Hartmann, A., Preiksaitis, J.K., Pescovitz, M.D., Rollag, H., Jardine, A.G. and Humar, A. (2011) The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response. Transplantation, 91(2), pp. 231-236. (doi:10.1097/TP.0b013e3181ff8719)

McQuarrie, E.P., Shakerdi, L., Jardine, A.G., Fox, J.G. and Mackinnon, B. (2011) Fractional excretions of albumin and IgG are the best predictors of progression in primary glomerulonephritis. Nephrology Dialysis Transplantation, 26(5), pp. 1563-1569. (doi:10.1093/ndt/gfq605)

Payne, C.J., Gibson, S.C., Bryce, G., Jardine, A.G., Berry, C. and Kingsmore, D.B. (2011) B-type natriuretic peptide predicts long-term survival after major non-cardiac surgery. British Journal of Anaesthesia, 107(2), pp. 144-149. (doi:10.1093/bja/aer119)

Payne, C.J., Payne, A.R., Gibson, S.C., Jardine, A.G., Berry, C. and Kingsmore, D.B. (2011) Is there still a role for preoperative 12-lead electrocardiography? World Journal of Surgery, 35(12), pp. 2611-2616. (doi:10.1007/s00268-011-1289-y)

Stevens, K.K. and Jardine, A.G. (2011) SHARP: a stab in the right direction in chronic kidney disease. Lancet, 377(9784), pp. 2153-2154. (doi:10.1016/S0140-6736(11)60822-2)

Stevens, K.K., McQuarrie, E.P., Sands, W., Hillyard, D.Z., Patel, R.K., Mark, P.B. and Jardine, A.G. (2011) Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation. International Journal of Nephrology, 2011(297070), pp. 1-6. (doi:10.4061/2011/297070)

Åsberg, A., Jardine, A.G., Bignamini, A. A., Rollag, H., Gahlemann, C. C., Humar, A. and Hartmann, A. (2011) Response to Letter About Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease. American Journal of Transplantation, 11(5), pp. 1103-1104. (doi:10.1111/j.1600-6143.2011.03500.x)

Holme, I., Fellstrom, B., Jardine, A. and Holdaas, H. (2010) Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients. Atherosclerosis, 208(1), pp. 234-239. (doi:10.1016/j.atherosclerosis.2009.06.020)

Blumberg, E.A., Hauser, I.A., Stanisic, S., Mueller, E., Berenson, K., Gahlemann, C.G., Humar, A. and Jardine, A.G. (2010) Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States. Transplantation, 90(12), pp. 1420-1426. (doi:10.1097/TP.0b013e3181ff500d)

Delles, C. and Jardine, A.G. (2010) Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes. Diabetologia, 54(1), pp. 4-6. (doi:10.1007/s00125-010-1942-2)

Edward, M., Quinn, J.A., Burden, A.D., Newton, B.B. and Jardine, A.G. (2010) Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Radiology, 256(3), pp. 735-743. (doi:10.1148/radiol.10091131)

Humar, A. et al. (2010) The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients. American Journal of Transplantation, 10(5), pp. 1228-1237. (doi:10.1111/j.1600-6143.2010.03074.x)

Humar, A., Limaye, A.P., Blumberg, E.A., Hauser, I.A., Vincenti, F., Jardine, A.G., Abramowicz, D., Ives, J.A.L., Farhan, M. and Peeters, P. (2010) Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study. Transplantation, 90(12), pp. 1427-1431. (doi:10.1097/TP.0b013e3181ff1493)

Mark, P. B., Patel, R. K. and Jardine, A. G. (2010) Screening for Coronary Artery Disease Before Renal Transplantation-Rational or Rationing? Transplantation, 89(7), pp. 807-808. (doi:10.1097/TP.0b013e3181cca6b6)

Patel, R.K., Jardine, A.G.M., Mark, P.B., Cunningham, A.F., Steedman, T., Powell, J.R., McQuarrie, E.P., Stevenson, K.K., Dargie, H.J. and Jardine, A.G. (2010) Association of left atrial volume with mortality among esrd patients with left ventricular hypertrophy referred for kidney transplant. American Journal of Kidney Diseases, 55(6), pp. 1088-1096. (doi:10.1053/j.ajkd.2009.12.033)

Stevens, K., Patel, R.K., Clancy, M. and Jardine, A.G. (2010) Angiotensin Blockade Is Associated With Early Graft Dysfunction After Live Donor Renal Transplantation. Transplantation, 89(6), pp. 707-709. (doi:10.1097/TP.0b013e3181c892f2)

Thomson, P. C., Collidge, T. A., Mark, P.B., Traynor, J.P., Jardine, A.G., Morris, S. T. W., Simpson, K. and Roditi, G. H. (2010) Correction to the Relative Risk Calculation for Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis Response. Radiology, 255(1), p. 308.

Åsberg, A., Jardine, A.G., Bignamini, A. A., Rollag, H., Pescovitz, M. D., Gahlemann, C. C., Humar, A. and Hartmann, A. (2010) Effects of the Intensity of Immunosuppressive Therapy on Outcome of Treatment for CMV Disease in Organ Transplant Recipients. American Journal of Transplantation, 10(8), pp. 1881-1888. (doi:10.1111/j.1600-6143.2010.03114.x)

Patel, R., Oliver, S., Mark, P., Powell, J., McQuarrie, E., Traynor, J., Dargie, H. and Jardine, A. (2009) Determinants of Left Ventricular Mass and Hypertrophy in Hemodialysis Patients Assessed by Cardiac Magnetic Resonance Imaging. Clinical Journal of the American Society of Nephrology, 4(9), pp. 1477-1483. (doi:10.2215/CJN.03350509)

Wu, O., Levy, A.R., Briggs, A., Lewis, G. and Jardine, A. (2009) Acute rejection and chronic nephropathy: a systematic review of the literature. Transplantation, 87(9), pp. 1330-1339. (doi:10.1097/TP.0b013e3181a236e0)

Asberg, A. et al. (2009) Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients. American Journal of Transplantation, 9(5), pp. 1205-1213.

Boivin, G., Goyette, N., Rollag, H., Jardine, A., Pescovitz, M., Asberg, A., Ives, J., Hortmann, A. and Humar, A. (2009) Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir. Antiviral Therapy, 14(5), pp. 697-704.

Brown, M., Gaffney, D., Gemmell, C., Oakes, E., Morris, S., Spooner, R., Jardine, A. and Geddes, C. (2009) Hemochromatosis gene mutations and treatment of anemia in patients on hemodialysis. Hemodialysis International, 13(4), pp. 460-466.

Fellstrom, B., Holdaas, H., Jardine, A., Svensson, M., Gottlow, M., Schmieder, R. and Zannad, F. (2009) Cardiovascular disease in patients with renal disease: the role of statins. Current Medical Research and Opinion, 25(1), pp. 271-285.

Fellstrom, B., Jardine, A. and Holdaas, H. (2009) Rosuvastatin in Patients Undergoing Hemodialysis REPLY. New England Journal of Medicine, 361(1), pp. 94-95.

Fellstrom, B. et al. (2009) Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis. New England Journal of Medicine, 360(14), pp. 1395-1407. (doi:10.1056/NEJMoa0810177)

Humar, A., Asberg, A., Kumar, D., Hartmann, A., Moussa, G., Jardine, A., Rollag, H., Mouas, H., Gahlemann, C. and Pescovitz, M. (2009) An Assessment of Herpesvirus Co-infections in Patients with CMV Disease: Correlation with Clinical and Virologic Outcomes. American Journal of Transplantation, 9(2), pp. 374-381.

Manuel, O. et al. (2009) Impact of Genetic Polymorphisms in Cytomegalovirus Glycoprotein B on Outcomes in Solid-Organ Transplant Recipients with Cytomegalovirus Disease. Clinical Infectious Diseases, 49(8), pp. 1160-1166.

Powell, J., Oluwaseun, O., Woo, Y., Padmanabhan, N., Narasinghan, E., Latta, C., Tortolano, J., Jardine, A. and Geddes, C. (2009) Ten Years Experience of In-Center Thrice Weekly Long Overnight Hemodialysis. Clinical Journal of the American Society of Nephrology, 4(6), pp. 1097-1101.

Patel, R., Mark, P., Johnston, N., McGeoch, R., Lindsay, M., Dargie, H. and Jardine, A. (2008) Cardiovascular screening of potential renal transplant recipients provides no survival benefit. American Journal of Transplantation, 8(s2), pp. 597-598. (doi:10.1111/j.1600-6143.2008.02255.x)

Edward, M., Quinn, J.A., Mukherjee, S., Jensen, M.B., Jardine, A.G., Mark, P. and Burden, A. (2008) Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. Journal of Pathology, 214(5), pp. 584-593. (doi:10.1002/path.2311)

Doyle, A., Mark, P.B., Johnston, N., Foster, J., Connell, J., Dargie, H., Jardine, A. and Padmanabhan, N. (2008) Aortic stiffness and diastolic flow abnormalities in end-stage renal disease assessed by magnetic resonance imaging. Nephron Clinical Practice, 109(1), C1-C8. (doi:10.1159/000130170)

Mackinnon, B., Padmanabhan, S., Murray, L., Sloan, W., Meredith, P., Reid, J., Walters, M., Jardine, A., Simpson, K. and McInnes, G. (2008) Is end stage renal disease a common outcome among patients attending a hypertension clinic? Journal of Hypertension, 26, S112-S112.

Mark, P., Doyle, A., Blyth, K., Patel, R., Weir, R., Steedman, T., Foster, J., Dargie, H. and Jardine, A. (2008) Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. Journal of Cardiovascular Magnetic Resonance, 10(39), (doi:10.1186/1532-429X-10-39)

McDonald, K. and Jardine, A. (2008) The use of fluvastatin in cardiovascular risk management. Expert Opinion on Pharmacotherapy, 9(8), pp. 1407-1414.

O'Connor, S., Jardine, A. and Millar, K. (2008) The prediction of self-care behaviors in end-stage renal disease patients using Leventhal's Self-Regulatory Model. Journal of Psychosomatic Research, 65(2), pp. 191-200. (doi:10.1016/j.jpsychores.2008.02.008)

Patel, R.K., Mark, P.B., Johnston, N., McGeoch, R., Lindsay, M., Kingsmore, D.B., Dargie, H.J. and Jardine, A.G. (2008) Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. American Journal of Transplantation, 8(8), pp. 1673-1683. (doi:10.1111/j.1600-6143.2008.02281.x)

Patel, R., Mark, P., Johnston, N., McGregor, E., Dargie, H. and Jardine, A. (2008) Renal Transplantation Is Not Associated with Regression of Left Ventricular Hypertrophy: A Magnetic Resonance Study. Clinical Journal of the American Society of Nephrology, 3(6), pp. 1807-1811. (doi:10.2215/CJN.01400308)

Murphy, C.L., Fitzsimons, E.J., Jardine, A.J., Sattar, N. and McMurray, J.J.V. (2007) 103 routine assessment of iron status in all patients with heart failure may identify those at risk of developing anaemia. European Journal of Heart Failure, 6(1), p. 24. (doi:10.1016/s1567-4215(07)60065-4)

Mark, P. B., Petrie, C. J. and Jardine, A. G. (2007) Diagnostic, prognostic, and therapeutic implications of brain natriuretic peptide in dialysis and nondialysis-dependent chronic renal failure. Seminars in Dialysis, 20, pp. 40-49. (doi:10.1111/j.1525-139X.2007.00240.x)

Asberg, A., Humar, A., Rollag, H., Jardine, A., Mouas, H., Pescovitz, M., Sgarabotto, D., Tuncer, M., Noronha, I. and Hartmann, A. (2007) Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. American Journal of Transplantation, 7, pp. 2106-2113. (doi:10.1111/j.1600-6143.2007.01910.x)

Collidge, T., Jardine, A., Mark, P., Morris, S., Roditi, G., Simpson, K., Thomson, P. and Traynor, J. (2007) Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort. Radiology, 245(1), pp. 168-175.

Dawes, H.A., Docherty, T., Traynor, I., Gilmore, D.H., Jardine, A.G. and Knill-jones, R. (2007) Specialist nurse supported discharge in gynaecology: A randomised comparison and economic evaluation. European Journal of Obstetrics and Gynecology and Reproductive Biology, 130(2), pp. 262-270.

Fellstrom, B., Holdaas, H., Jardine, A., Rose, H., Schmieder, R., Wilpshaar, W. and Zannad, F. (2007) Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study. Kidney and Blood Pressure Research, 30, pp. 314-322. (doi:10.1159/000106803)

Gardner, R., Chong, K., O'Meara, E., Jardine, A., Ford, I. and McDonagh, T. (2007) Renal dysfunction, as measured by the modification of diet in renal disease equations, and outcome in patients with advanced heart failure. European Heart Journal, 28(24), pp. 3027-3033.

Hillyard, D., Nutt, C., Thomson, J., McDonald, K., Wan, R., Cameron, A., Mark, P. and Jardine, A. (2007) Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis, 191, pp. 319-325. (doi:10.1016/j.atherosclerosis.2006.05.037)

Joss, N., Staatz, C., Thomson, A. and Jardine, A. (2007) Predictors of new onset diabetes after renal transplantation. Clinical Transplantation, 21, pp. 136-143. (doi:10.1111/j.1399-0012.2006.00580.x)

Mark, P. B., Patel, R. K. and Jardine, A. G. (2007) Are we overestimating left ventricular abnormalities in end-stage renal disease? Nephrology Dialysis Transplantation, 22(7), pp. 1815-1819. (doi:10.1093/ndt/gfm224)

Oppenheimer, F. et al. (2007) Impact of long-term therapy with FTY720 or mycophenolate mofetil on cardiac conduction and rhythm in stable adult renal transplant patients. Transplantation, 83(5), pp. 645-648.

Singer, J., Holdaas, H., Jardine, A., Fellstrom, B., Os, I., Bermann, G. and Meyer, J. (2007) Genetic analysis of fluvastatin response and dyslipidemia in renal transplant recipients. Journal of Lipid Research, 48, pp. 2072-2078. (doi:10.1194/jlr.M700076-JLR200)

Wan, R., Mark, P. and Jardine, A. (2007) The cholesterol paradox is flawed; Cholesterol must be lowered in dialysis patients. Seminars in Dialysis, 20, pp. 504-509. (doi:10.1111/j.1525-139X.2007.00359.x)

Zimmerli, L., Mark, P., Steedman, T., Foster, J., Berg, G., Dargie, H., Jardine, A., Delles, C. and Dominiczak, A. (2007) Vascular function in patients with end-stage renal disease and/or coronary artery disease: A cardiac magnetic resonance imaging study. Kidney International, 71(1), pp. 68-73. (doi:10.1038/sj.ki.5002024)

Wan, R. K., Mark, P. B. and Jardine, A. G. (2006) Cardiovascular disease management in renal transplant recipients: more or less treatment? Transplantation, 82(6), pp. 737-738. (doi:10.1097/01.tp.0000235431.71677.e3)

Mark, P.B. and Jardine, A.G. (2006) Cardiovascular magnetic resonance imaging has much to offer in the assessment of renal transplant recipients. American Journal of Transplantation, 6(8), pp. 1975-1976. (doi:10.1111/j.1600-6143.2006.01376.x)

Fellstrom, B., Abedini, S., Holdaas, H., Jardine, A., Staffler, B., Gimpelewicz, C. and ALERT Study Grp, (2006) No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study. Clinical Transplantation, 20, pp. 732-739. (doi:10.1111/j.1399-0012.2006.00555.x)

Mark, P.B., Johnston, N., Groenning, B.A., Foster, J.E., Blyth, K., Martin, T.N., Steedman, T., Dargie, H.J. and Jardine, A.G. (2006) Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney International, 69(10), pp. 1839-1845. (doi:10.1038/sj.ki.5000249)

Mark, P., Stewart, G., Gansevoort, R., Petrie, C., McDonagh, T., Dargie, H., Rodger, R. and Jardine, A. (2006) Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrology Dialysis Transplantation, 21, pp. 402-410. (doi:10.1093/ndt/gfi187)

O'Meara, E., Chong, K., Gardner, R., Jardine, A., Neilly, J. and McDonagh, T. (2006) The Modification of Diet in Renal Disease (MDRD) equations provide valid estimations of glomerular filtration rates in patients with advanced heart failure. European Journal of Heart Failure, 8(1), pp. 63-67. (doi:10.1016/j.ejheart.2005.04.013)

Oien, C., Reisaeter, A., Os, I., Jardine, A., Fellstrom, B. and Holdaas, H. (2006) Gender-associated risk factors for cardiac end points and total mortality after renal transplantation: post hoc analysis of the ALERT study. Clinical Transplantation, 20, pp. 374-382. (doi:10.1111/j.1399-0012.2006.00496.x)

Soveri, I., Holdaas, H., Jardine, A., Gimpelewicz, C., Staffler, B. and Fellstrom, B. (2006) Renal transplant dysfunction - importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality. Nephrology Dialysis Transplantation, 21, pp. 2282-2289. (doi:10.1093/ndt/gfl095)

Wan, R. and Jardine, A. (2006) The impact and treatment of obesity and dyslipidaemias in renal transplantation. Current Opinion in Organ Transplantation, 11, pp. 401-406.

Mark, P.B., Murphy, K., Mohammed, A.S., Morris, S.T.W. and Jardine, A.G. (2005) Endothelial dysfunction in renal transplant recipients. Transplantation Proceedings, 37(9), pp. 3805-3807. (doi:10.1016/j.transproceed.2005.09.116)

Fellstrom, B., Zannad, F., Schmieder, R., Holdaas, H., Jardine, A., Rose, H. and Wilspshaar, W. (2005) Effect of rosuvastatin on outcomes in chronic haemodialysis patients - Design and rationale of the AURORA study. Current Controlled Trials in Cardiovascular Medicine, 6, p. 9. (doi:10.1186/1468-6708-6-9)

Tutone, V.K., Mark, P.B., Stewart, G.A., Tan, C.C., Rodger, R.S.C., Geddes, C.C. and Jardine, A.G. (2005) Hypertension, antihypertensive agents and outcomes following renal transplantation. Clinical Transplantation, 19(2), pp. 181-192. (doi:10.1111/j.1399-0012.2004.00315.x)

Stewart, G., Gansevoort, R., Mark, P., Rooney, E., McDonagh, T., Dargie, H., Stuart, R., Rodger, C. and Jardine, A. (2005) Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney International, 67(1), pp. 217-226. (doi:10.1111/j.1523-1755.2005.00072.x)

Fellstrom, B. et al. (2005) Risk factors for reaching renal Endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) trial. Transplantation, 79, pp. 205-212. (doi:10.1097/01.TP.0000147338.34323.12)

Fellstrom, B. et al. (2005) Effect of rosuvastatin on outcomes in chronic haemodialysis patients - Design and rationale of the AURORA study. Current Controlled Trials in Cardiovascular Medicine, 6(9), (doi:10.1159%2F000106803)

Holdaas, H. et al. (2005) Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. American Journal of Transplantation, 5, pp. 2929-2936. (doi:10.1111/j.1600-6143.2005.01105.x)

Holdaas, H. et al. (2005) Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrology Dialysis Transplantation, 20, pp. 974-980. (doi:10.1093/ndt/gfh735)

Jardine, A. (2005) Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine. Transplant International, 18, pp. 379-384. (doi:10.1111/j.1432-2277.2005.00080.x)

Jardine, A. et al. (2005) Cardiovascular risk and renal transplantation: Post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) study. American Journal of Kidney Diseases, 46, pp. 529-536. (doi:10.1053/j.ajkd.2005.05.014)

Joss, N., Jardine, A., Gaffney, D. and Boulton-Jones, J. (2005) Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Experimental Nephrology, 101, E127-E133. (doi:10.1159/000087577)

McLean, D. and Jardine, A. (2005) A simulation model to investigate the impact of cardiovascular risk in renal transplantation. Transplantation Proceedings, 37, pp. 2135-2143. (doi:10.1016/j.transproceed.2005.03.057)

Mohamed, A., Thomson, J., McDonald, K., Hillyard, D., Mark, P., Elliott, H. and Jardine, A. (2005) Circulating endothelial cells in renal transplant recipients. Transplantation Proceedings, 37, pp. 2387-2390. (doi:10.1016/j.transproceed.2005.03.126)

Wilkinson, A. et al. (2005) Guidelines for the treatment and management of new-onset diabetes after transplantation. Clinical Transplantation, 19, pp. 291-298. (doi:10.1111/j.1399-0012.2005.00359.x)

Tutone, V.K., Mark, P.B., Revanur, V., Traynor, J., Buist, L.J., Geddes, C.C., Deardon, D. and Jardine, A.G. (2004) Random blood glucose measurements and survival in nondiabetic renal transplant recipients. Transplantation Proceedings, 36(10), pp. 3006-3011. (doi:10.1016/j.transproceed.2004.10.067)

Hillyard, D.Z., Cameron, A.J.M., McDonald, K.J., Thomson, J., MacIntyre, A., Shiels, P.G., Panarelli, M. and Jardine, A.G. (2004) Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease. Atherosclerosis, 175(2), pp. 305-313. (doi:10.1016/j.atherosclerosis.2004.03.018)

Cowan, M., Dargie, H., Foster, J., Jardine, A., Johnston, N., Mark, P., Rodger, R. and Stewart, G. (2004) Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clinical Physiology and Functional Imaging, 24, pp. 387-393.

Hillyard, D., Jardine, A., McDonald, K. and Cameron, A. (2004) Fluvastatin inhibits raft dependent Fc gamma receptor signalling in human monocytes. Atherosclerosis, 172, pp. 219-228. (doi:10.1016/j.atherosclerosis.2003.11.004)

Jardine, A. and Geddes, C. (2004) Cyclosporine in renal transplantation: A Scottish experience. Transplantation Proceedings, 36, 139S-142S. (doi:10.1016/j.transproceed.2003.12.052)

Jardine, A. et al. (2004) Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT study. American Journal of Transplantation, 4, pp. 988-995. (doi:10.1111/j.1600-6143.2004.00445.x)

McDonald, K., McMillan, M., Rodger, R., Junor, B., Geddes, C., Briggs, J. and Jardine, A. (2004) Persistent dipstick haematuria following renal transplantation. Clinical Transplantation, 18, pp. 321-326.

Stanton, T., Payne, J.R., Montgomery, H.E., Watt, G., Dominiczak, A.F., Jardine, A.G. and Connell, J.M. (2003) Genetic determinants of left ventricular mass: the role of beta-1 adrenoceptor variation in normal, athletic, and disease populations. Journal of the American College of Cardiology, 41(6 (S1)), p. 273. (doi:10.1016/S0735-1097(03)82282-9)

Asberg, A., Holdaas, H., Jardine, A., Edvardsen, C. and Hartmann, A. (2003) Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation. Clinical Transplantation, 17, pp. 385-390.

Crilly, A., Hamilton, J., Clark, C., Jardine, A. and Madhok, R. (2003) Analysis of the 5 ' flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology, 42, pp. 1295-1298. (doi:10.1093/rheumatology/keg420)

Geddes, C., Rauta, V., Gronhagen-Riska, C., Bartosik, L., Jardine, A., Ibels, L., Pei, Y. and Cattran, D. (2003) A tricontinental view of IgA nephropathy. Nephrology Dialysis Transplantation, 18, pp. 1541-1548. (doi:10.1093/ndt.gfg207)

Holdaas, H. et al. (2003) Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet, 361, pp. 2024-2031.

Joosten, S.A., van Ham, V., Nolan, C.E., Borrias, M.C., Jardine, A.G., Shiels, P.G., van Kooten, C. and Paul, L.C. (2003) Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. American Journal of Pathology, 162(4), pp. 1305-1312. (doi:10.1016/S0002-9440(10)63926-0)

Crilly, A., Hamilton, J., Clark, C., Jardine, A. and Madhok, R. (2002) Analysis of transforming growth factor beta 1 gene polymorphisms in patients with systemic sclerosis. Annals of the Rheumatic Diseases, 61, pp. 678-681.

Geddes, C., Woo, Y. and Jardine, A. (2002) The impact of delayed graft function on the long-term outcome of renal transplantation. Journal of Nephrology, 15, pp. 17-21.

Hillyard, D., Cameron, A., McIntyre, A., Hadden, M., Marshall, H., Johnston, N. and Jardine, A. (2002) Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin. Clinical and Experimental Pharmacology and Physiology, 29, pp. 673-678.

McDonald, K., Cameron, A., Allen, J. and Jardine, A. (2002) Expression of Fc alpha/mu receptor by human mesangial cells: A candidate receptor for immune complex deposition in IgA nephropathy. Biochemical and Biophysical Research Communications, 290, pp. 438-442. (doi:10.1006/bbrc.2001.6218)

Stanton, T., Inglis, G.C., Padmanabhan, S., Dominiczak, A.F., Jardine, A.G. and Connell, J.M. (2002) Variation at the beta-1 adrenoceptor gene locus affects left ventricular mass in renal failure. Journal of Nephrology, 15(5), pp. 512-518.

Woo, Y. et al. (2002) The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation. Journal of Nephrology, 15, pp. 380-386.

Joseph, J., Kingsmore, D., Junior, B., Briggs, J., Woo, Y., Jaques, B., Hamilton, D., Jardine, A. and Jindal, R. (2001) The impact of late acute rejection after cadaveric kidney transplantation. Clinical Transplantation, 15, pp. 221-227.

Morris, S., McMurray, J., Spiers, A. and Jardine, A. (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney International, 60, pp. 1077-1082.

Revanur, V., Jardine, A., Kingsmore, D., Jaques, B., Hamilton, D. and Jindal, R. (2001) Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation. Clinical Transplantation, 15, pp. 89-94.

Morris, S. T.W., McMurray, J. J.V. , Rodger, R. S. C., Farmer, R. and Jardine, A. G. (2000) Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney International, 57(3), pp. 1100-1106. (doi:10.1046/j.1523-1755.2000.00937.x) (PMID:10720962)

Morris, S.T.W., McMurray, J.J.V. , Rodger, R.S.C., Briggs, J.D. and Jardine, A.G. (1999) Impaired vascular responsiveness to nitric oxide in renal transplant recipients. Transplantation Proceedings, 31(1-2), pp. 304-305. (doi:10.1016/s0041-1345(98)01637-6) (PMID:10083118)

Northridge, D. B., Jamieson, M. P., Jardine, A. G., MacArthur, K. J.D., MacFarlane, N. and Dargie, H. J. (1992) Pulmonary extraction and left atrial secretion of atrial natriuretic factor during cardiopulmonary bypass surgery. American Heart Journal, 123(3), pp. 698-703. (doi:10.1016/0002-8703(92)90509-T) (PMID:1531724)

Book Sections

Mark, P., Stevens, K. and Jardine, A. (2013) Electrolytes: acid–base balance. In: Caballero, B., Allen, L. and Prentice, A. (eds.) Encyclopedia of Human Nutrition. Academic Press: Waltham, MA, pp. 139-145. ISBN 9780123750839

Mark, P. and Jardine, A. (2012) Assessment of the potential renal transplant recipient. In: MacPhee, I. A. M. and Froněck, J. (eds.) Handbook of Renal and Pancreatic Transplantation. Wiley-Blackwell: Oxford, pp. 8-31. ISBN 9780470654910

Mark, P. B., Jardine, A. G., Roditi, G. H. and Brady, A. J. (2009) Renal artery stenosis. In: Donnelly, R. and London, N. J. (eds.) ABC of Arterial and Venous Disease. Series: BMJ Books. Wiley-Blackwell: Oxford, pp. 37-43. ISBN 9781405178891

Jardine, A. G., Mark, P. B., Holdaas, H. and Fellstrøm, B. (2009) Special patient populations: chronic renal disease. In: Ballantyne, C. M. (ed.) Lipidology: A Companion To Braunwald's Heart Disease. Elsevier: Oxford, pp. 500-508. ISBN 9781416054696

This list was generated on Tue Jul 25 19:23:35 2017 BST.